|
May 10
|
Q1 2024 Viatris Inc Earnings Call
|
|
May 9
|
Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast
|
|
May 9
|
Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down
|
|
May 9
|
Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
May 9
|
Viagra maker Viatris misses revenue estimates on weak demand for older drugs
|
|
May 9
|
Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates
|
|
May 9
|
Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges
|
|
May 8
|
Why Earnings Season Could Be Great for Viatris (VTRS)
|
|
May 6
|
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
|
|
May 6
|
Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?
|
|
May 6
|
Viatris (VTRS) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
|
May 2
|
Viatris to Participate in the BofA Securities 2024 Health Care Conference
|
|
May 2
|
Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?
|
|
May 1
|
Viatris Expands Its Wellbeing Program With the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health
|
|
May 1
|
Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health
|
|
Apr 21
|
11 Best Low Price Pharma Stocks To Invest In
|
|
Apr 19
|
Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris
|
|
Apr 18
|
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
|
|
Apr 18
|
Bill Miller’s Latest 13 Stock Picks
|
|
Apr 16
|
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
|